New research looks at treatments for genetic syndrome linked to autism, schizophrenia

Updated: Apr. 26, 2023 at 3:00 PM EDT
Email This Link
Share on Pinterest
Share on LinkedIn

ROANOKE, Va. (WDBJ) - New research has identified a way to possibly disrupt a genetic syndrome and prevent autism and schizophrenia in its patients.

Dr. Anthony-Samuel LaMantia is a professor at the Fralin Biomedical Research Institute at Virginia Tech Carilion.

He will be leading a five-year study to see how a key factor in genetic development could offer a narrow opportunity to address DiGeorge syndrome. DiGeorge syndrome is a genetic disorder that affects about 1 in 3,000 babies and begins with the deletion of one of two copies of a small number of genes on human chromosome 22.

DiGeorge syndrome is one of the common few genetic syndromes that is associated with a high risk for developing autism and schizophrenia later in life, according to VTC.

LaMantia joined Here @ Home to talk more about the goals of his ongoing research and how he hopes this type of study will benefit human health on a larger scale beyond this unique syndrome.